Coagulopathy: Another side effect of coronavirus infection

Link to article at PubMed

J Cardiovasc Thorac Res. 2021;13(1):15-22. doi: 10.34172/jcvtr.2020.59. Epub 2020 Dec 23.

ABSTRACT

Recently, coronavirus disease 2019 (COVID-19) has been considered as a major health problem around the globe. This severe acute respiratory syndrome has a bunch of features, such as high transmission rate, which are adding to its importance. Overcoming this disease relies on a complete understanding of the viral structure, receptors, at-risk cells or tissues, and pathogenesis. Currently, researches have shown that besides the lack of a proper anti-viral therapeutic method, complications provided by this virus are also standing in the way of decreasing its mortality rate. One of these complications is believed to be a hematologic manifestation. Commonly, three kinds of coagulopathies are detected in COVID-19 patients: disseminated intravascular coagulation (DIC), pulmonary embolism (PE), and deep vein thrombosis (DVT). In this paper, we have reviewed the relation between these conditions and coronavirus-related diseases pathogenesis, severity, and mortality rate.

PMID:33815697 | PMC:PMC8007900 | DOI:10.34172/jcvtr.2020.59

Leave a Reply

Your email address will not be published.